Updated on 24 January 2015
--By Lance Little
In most Asian countries there is an increasing prevalence of non-communicable diseases and therefore there are many un-met medical requirements that need to be addressed. There is also seeing increasing modernization of healthcare infrastructure, especially in emerging markets. On the regulatory side, we observe increasing regulatory hurdles and also harmonization of the ASEAN regulatory framework. With the focus of many counties to reduce costs by taking people of the hospital system, we are seeing a strong demand for Point of care technology.
The year, 2014, was a great for Roche Diagnostics in Asia Pacific. During the first 9 months of 2014, the Roche Diagnostics Division reported strong global sales growth of 6 percent (7.8 billion Swiss francs) which was driven by strong performance by Professional Diagnostics. All regions contributed to growth and Asia-Pacific was one of the key drivers of growth at 15 percent.
Roche Diagnostics has identified a number of focus countries for the next years to come and much of our attention will be placed here. At the same time, we will be looking at areas of growth for China. Furthermore, we will focus as a whole region on strengthening our commercial operations.
We will also be launching a new Centre of Excellence in Singapore, which along with China, will become the training hub for the region. Asia Pacific is a rapidly developing region and there are still a lot of opportunities for the diagnostics industry. The region will continue to experience low double digit growth in 2015. Roche Diagnostics plans to continue to grow above the market in Asia Pacific.